StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30538% above fair value
$60.85−0.51 (-0.83%)

Close on Nov 20, 2026Market cap $1.74BP/E 156.0Yield –

Eton Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Eton Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was $14.73M, up 20.5% year over year. For fiscal 2025 it was $10.19M, up 980.7% from the year before. The highest annual figure on record is $10.19M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.19M+980.7%
FY2024Dec 31, 2024$943.00K-86.2%
FY2023Dec 31, 2023$6.82M+42.5%
FY2022Dec 31, 2022$4.78M–
FY2021Dec 31, 2021-$4.73M–
FY2020Dec 31, 2020-$22.40M–
FY2019Dec 31, 2019-$19.12M–
FY2018Dec 31, 2018-$8.38M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.26M-8.8%
Q1 FY2026Mar 31, 2026$7.33M+250.7%
Q4 FY2025Dec 31, 2025-$11.60M–
Q3 FY2025Sep 30, 2025$11.74M+297.8%
Q2 FY2025Jun 30, 2025$7.96M+534.2%
Q1 FY2025Mar 31, 2025$2.09M–
Q4 FY2024Dec 31, 2024-$777.00K-300.8%
Q3 FY2024Sep 30, 2024$2.95M+238.1%
Q2 FY2024Jun 30, 2024$1.26M-82.3%
Q1 FY2024Mar 31, 2024-$2.49M–
Q4 FY2023Dec 31, 2023$387.00K-86.3%
Q3 FY2023Sep 30, 2023$873.00K–
Q2 FY2023Jun 30, 2023$7.10M+189.9%
Q1 FY2023Mar 31, 2023-$1.55M-228.1%
Q4 FY2022Dec 31, 2022$2.83M–
Q3 FY2022Sep 30, 2022-$1.70M–
Q2 FY2022Jun 30, 2022$2.45M–
Q1 FY2022Mar 31, 2022$1.21M–
Q4 FY2021Dec 31, 2021-$5.12M–
Q3 FY2021Sep 30, 2021-$2.95M–
Q4 FY2020Dec 31, 2020-$7.23M–
Q3 FY2020Sep 30, 2020-$5.10M–
Q2 FY2020Jun 30, 2020-$2.85M–
Q1 FY2020Mar 31, 2020-$7.22M–
Q4 FY2019Dec 31, 2019-$3.88M–
Q3 FY2019Sep 30, 2019-$3.25M–
Q2 FY2019Jun 30, 2019-$4.84M–
Q1 FY2019Mar 31, 2019-$7.16M–
Q4 FY2018Dec 31, 2018-$1.83M–
Q3 FY2018Sep 30, 2018-$2.34M–
Q2 FY2018Jun 30, 2018-$2.27M–
Q1 FY2018Mar 31, 2018-$1.94M–

More Eton Pharmaceuticals figures

See a number that looks wrong?